Efficacy of ursodeoxycholic acid administration as adjuvant therapy together with alfa-interferon for chronic hepatitis C.

被引：0
|
作者：
Fabbri, C [1 ]
Mazzella, G [1 ]
Marchetto, S [1 ]
Pezzoli, A [1 ]
Fusaroli, P [1 ]
Accogli, E [1 ]
Azzaroli, F [1 ]
Mazzeo, C [1 ]
Jaboli, F [1 ]
Roda, E [1 ]
机构：
[1] UNIV BOLOGNA, DEPT INTERNAL MED & GASTROENTEROL, BOLOGNA, ITALY
来源：
GASTROENTEROLOGY | 1997年 / 112卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A1261 / A1261
页数：1
相关论文
共 50 条
  • [41] High efficacy of combination therapy with pegylated interferon and ribavirin in hemophiliacs with chronic hepatitis C.
    Mancuso, ME
    Santagostino, E
    Rumi, MG
    Linari, S
    Coppola, A
    Rocino, A
    Iorio, A
    Dragani, A
    Barillari, G
    Tagariello, G
    Nicolin, R
    Colombo, M
    Mannucci, PM
    BLOOD, 2005, 106 (11) : 899A - 900A
  • [42] Recombinant interferon-alfa therapy in children with chronic hepatitis C
    Bortolotti, F
    Giacchino, R
    Vajro, P
    Barbera, C
    Crivellaro, C
    Alberti, A
    Nebbia, G
    Zancan, L
    DeMoliner, L
    Bertolini, A
    Balli, F
    Callea, F
    HEPATOLOGY, 1995, 22 (06) : 1623 - 1627
  • [43] Nephrotoxicity of interferon alfa-ribavirin therapy for chronic hepatitis C
    Willson, RA
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2002, 35 (01) : 89 - 92
  • [44] A randomized comparison of standard and reinforced schedules of alfa interferon in chronic hepatitis C.
    Degos, F
    Daurat, V
    Gayno, S
    Bastie, A
    Riachi, G
    Ellouk, AS
    Barange, K
    Portal, I
    Moussalli, J
    Chastang, C
    HEPATOLOGY, 1996, 24 (04) : 596 - 596
  • [45] Ursodeoxycholic acid (UDCA) and interferon (IF) combined therapy of chronic viral C hepatitis: A meta-analysis
    Dumitrascu, DL
    Sandor, V
    JOURNAL OF HEPATOLOGY, 2003, 38 : 136 - 136
  • [46] Combination of interferon alfa-2a and amantadine does not improve the efficacy of interferon therapy in patients with chronic hepatitis C
    Yang, SS
    Tu, LC
    Wu, CH
    Chen, DS
    HEPATO-GASTROENTEROLOGY, 2003, 50 (53) : 1575 - 1578
  • [47] Effect of adjuvant tauro-ursodeoxycholic acid (t-UDCA) for interferon (IFN) treatment of chronic hepatitis C. Results on liver histology.
    Pigozzi, MG
    Sorbara, R
    Reggiani, A
    DeTavonatti, M
    Distefano, L
    Bettini, L
    Lorini, GP
    Lazzari, C
    Cominotti, A
    Favret, M
    Sosta, S
    Lanzini, A
    HEPATOLOGY, 1997, 26 (04) : 360 - 360
  • [48] Efficacy of short-term ribavirin plus interferon alfa combination therapy followed by interferon alfa alone in previously untreated patients, with chronic hepatitis C. A randomized trial.
    Berg, T
    Hoffmann, RM
    Teuber, G
    Leifeld, L
    Lawrenz, M
    Baumgarten, R
    Spengler, U
    Zeuzem, S
    Pape, GR
    Hopf, U
    HEPATOLOGY, 1998, 28 (04) : 373A - 373A
  • [49] Safety, efficacy, and pharmacokinetics of interferon alfa-2b plus ribavirin in children with chronic hepatitis C.
    Kelly, DA
    Bunn, SK
    Apelian, D
    Baczkowski, A
    Gupta, S
    Laughlin, M
    Cohard, M
    HEPATOLOGY, 2001, 34 (04) : 342A - 342A
  • [50] Combination therapy with interferon alfa and ribavirin as retreatment of interferon relapse in chronic hepatitis C
    Davis, GL
    SEMINARS IN LIVER DISEASE, 1999, 19 : 49 - 55
12345